Ibtrozi Rollout Momentum Makes Nuvation Bio a Modest Buy
Nuvation Bio (NUVB) has traded off sharply since its 52-week high, but supportive rollout commentary on Ibtrozi, a solid cash position and a beaten-down technical set create an asymmetric risk/reward for a measured long. This trade idea lays out entry, stop and target with horizon and risk framing.